Global Drug Makers Scale Back Sales Expectations In Emerging Markets
This article was originally published in PharmAsia News
Executive Summary
Emerging markets, primarily China and India, may not be the panacea for global drug makers seeking sales growth, the industry, including members Eli Lilly and Pfizer, are discovering.